Discussions

What the Global Fund gave us

by Sharonann Lynch

What the Global Fund gave us was 17 years of scaling up lifesaving HIV and TB treatment and pooling volumes in order to negotiate lower prices that are transparent. What the Global Fund gave us was setting a standard of quality for HIV and TB medicines, requiring approval from WHO ... read more

Updated: 19 Jul, 2019
Replies: 0

MSF: Annual reductions in AIDS deaths are not reducing enough

by Sharonann Lynch

MSF Press Release UNAIDS update: High ongoing AIDS mortality reminds us that the fight against HIV is far from over Brussels / Geneva / Johannesburg, 16 July 2019.770 000 people died of HIV worldwide in 2018. These are disturbing figures in the UNAIDS 2019 report released today in Eshowe, South ... read more

Updated: 17 Jul, 2019
Replies: 0

Diploma in Public Health (DPH)

by Bhupesh Advani

Diploma in Public Health (DPH) is an course in public health sciences. The duration of the course is of 1 year inclusive of Industrial visits, research projects and internship. The candidate during and after the training should be able to implement the knowledge, skills & advances of public health for ... read more

Updated: 28 Jun, 2019
Replies: 0

MSF: Gilead fails people living with HIV

by Sharonann Lynch

Please find below a press release from MSF calling out Gilead’s failure to deliver on the promise to provide liposomal amphotericin B (L-AmB), a key drug to treat cryptococcal meningitis, at a supposed ‘no profit’ price of $16.25/vial in 116 low and middle-income countries. Gilead Sciences fails on promise to ... read more

Updated: 27 Jun, 2019
Replies: 0

Infection control trends July 2019 edition is dedicated to Tuberculosis

Claudia Mutaquiha replied

Hi. I´am interested to contribute on MDR and XDR TB. Thank you Cláudia Mutaquiha Ponto Focal Nacional de TB MR Dr Dhruv Mamtora via GHDonline <drtb@ghdonline.org> escreveu no dia terça, read more

Updated: 11 Jun, 2019
Reply: 1

MSF: The risks of the Global Fund 'procurement cliff'

by Sharonann Lynch

Hello, Please find a MSF editorial in WHO Bulletin regarding the risks to quality, affordability, and supply of HIV and TB medical commodities with the shift from Global Fund-supported pooled procurement to national systems. The PDF is here https://www.who.int/bulletin/volumes/97/5/19-234468.pdf It is not only countries that are facing transition that are ... read more

Updated: 02 May, 2019
Replies: 0

McGill Summer Institute in Infectious Diseases and Global Health--Now accepting applications for 2019

by Madhukar Pai

Please see this announcement: https://mailchi.mp/mcgill/mcgill-summer-institute-in-infectious-diseases-and-global-health-now-accepting-applications-for-1974345 This year, we are offering a selection of our most popular courses in a shortened 3-day intensive format, in addition to an original 5-day course. Participants now have the opportunity to take up to 4 different topics during the two weeks. When: June 10-21, 2019 ... read more

Updated: 04 Dec, 2018
Replies: 0

Expressions of Interest - PNG TB specialist

by Khai Lin Huang

Dear Colleagues, In addition to our recently advertised positions, we are seeking expressions of interest from suitably qualified and experienced TB Medical Specialists to work with the Burnet based in PNG. For full details including how to apply, please go to the link below: https://burnet.applynow.net.au/jobs/BI201820213-expressions-of-interest-png-tb-specialist Applications close 13th December 2018. ... read more

Updated: 03 Dec, 2018
Replies: 0

MSF to pharma: Stop failing children with HIV

by Sharonann Lynch

MSF criticises pharma for dragging feet on developing HIV drugs for children https://msfaccess.org/pharmaceutical-corporations-failing-children-hiv Geneva, 29 November 2018—Ahead of a Vatican City meeting on scaling up HIV diagnosis and treatment for children, the international medical humanitarian organisation Médecins Sans Frontières (MSF) criticised pharmaceutical corporations for their delays and failure to develop ... read more

Updated: 03 Dec, 2018
Replies: 0